The baseline SAQ-AF score was 73.3±22.8, and it rose by at least 10 points at 12 months in 63.1% of patients with a post-PCI iFR <0.90 as compared with 71% of patients with a post-PCI iFR ≥0.90, a difference that did not reach statistical significance (p=0.17).
← all excerpts
Review of Imaging and Physiology Late Breaking Trials From the TCT Connect 2020 Virtual Meeting.
1
0.1700
0.1700